Learn from China (Asia)
This article was originally published in PharmAsia News
Executive Summary
China's recent quality problems with food and pharmaceutical exports have tarnished its reputation and could become a concern for all of Asia's pharmaceutical industries. For instance, India imports large quantities of raw materials for antibiotics from China, and this has drawn concern from Indian and U.S. authorities. In fact, India exported around $800 million in drugs and pharmaceutical ingredients to the United States in 2006. This trade volume ranks above the $675 million of such products sent to the United States by China. Indian pharmaceutical laws are not evenly enforced or well-funded across all provinces. This one day may result in negative world attention such as the scandals experienced recently by China. (Click here for more